Cite
HARVARD Citation
Soifer, H. et al. (n.d.). HNSCCs overexpressing wild-type HRAS are sensitive to combined tipifarnib and alpelisib treatment. European journal of cancer. pp. S58-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Soifer, H. et al. (n.d.). HNSCCs overexpressing wild-type HRAS are sensitive to combined tipifarnib and alpelisib treatment. European journal of cancer. pp. S58-. [Online].